Priority Research Area Infections

Microbial Interface Biology

Mission   Projects   Funding   Techniques   Publications  Staff

PD Dr. Norbert Reiling
PD Dr. Norbert Reiling
04537 / 188-4860
This email address is being protected from spambots. You need JavaScript enabled to view it.


“To get it, all you have to do is breathe”-  A Tuberculosis infection is in most cases acquired through inhalation of Mycobacterium tuberculosis in aerosolized respiratory secretions from a contagious person coughing, sneezing or talking. In the lung the bacteria get into contact with alveolar macrophages. Whether these cells are capable to kill the bacteria depends on various parameters and processes, which happen at the microbial interface between M. tuberculosis and its host cell, the macrophage. 

This directly points towards the main focus of the Research group (RG) Microbial Interface Biology, which is the detailed characterization of the interaction between pathogenic mycobacteria of the M. tuberculosis complex (MTBC) and their target cells, the macrophages in order to identify of novel anti-mycobacterial pathways and compounds. To achieve our goals the RG has developed novel approaches to isolate und characterize intracellular compartments  from uninfected and M. tuberculosis-infected macrophagen (phagosomes, macropinosomes and lipid droplets). In addition the RG employs has developed several test systems to identify anti-mycobacterial lead compounds. In recent years the RG has significantly contributed to several patent applications, which focus on novel anti-mycobacterial and anti-inflammatory therapeutic concepts. Thus the current and also the future work do have direct translational impact. In this context several projects focus on the analysis and the modulation of the lipid metabolism in the interaction between host cells and M. tuberculosis.